Indeed, our work shows that AKR1B1 expression is repressed at the transcriptional level by p53 in cancer cell lines and that AKR1B1 mRNA levels are reduced in breast cancer patients’ tumors retaining wild-type TP53 (the gene encoding p53), as compared to tumors bearing mutations in this gene. This evidence concerns the gene AKR1B1 and breast carcinoma.